Skip to main content
Erschienen in: International Journal of Clinical Pharmacy 2/2013

01.04.2013 | Research Article

Evaluation of adherence to international guidelines for treating patients with type 2 diabetes mellitus in Kuwait

verfasst von: Dalal M. Al-Taweel, Abdelmoneim I. Awad, B. Julienne Johnson

Erschienen in: International Journal of Clinical Pharmacy | Ausgabe 2/2013

Einloggen, um Zugang zu erhalten

Abstract

Background Clinical guidelines derived from scientific evidence provide the basis of consistent standardized prescribing. Despite an alarming increase of diabetes in Kuwait, no studies related to the quality of prescribing in diabetes were found. Before pharmaceutical care can be implemented to improve the quality of care of patients with diabetes, it is important to determine whether prescribers are compliant with comprehensive international guidelines for cardioprevention and glycaemic control. Objective To evaluate the adherence to clinical guidelines for treating patients with type 2 diabetes mellitus in primary care centres and secondary care centres (hospitals) using a developed and validated medication assessment tool with reference to international guidelines. Setting Outpatient diabetes clinics in 8 primary care centres and 4 secondary care centres across four healthcare regions in Kuwait. Method A quantitative, cross-sectional study involving a sample of 652 Kuwaiti patients with type 2 diabetes, who were selected using systematic sampling from the study settings. Data were collected retrospectively from the patients’ medical records using a validated 43-criterion medication assessment tool (MATKW) designed to assess cardioprevention and treatment in patients with type 2 diabetes. Descriptive and comparative analysis was conducted using SPSS version 17. Main Outcome Measure Frequency of prescribing adherence to agreed definitions of criteria derived from international guidelines. Results Overall adherence to prescribing diabetes guidelines was 77.7 % (95 % CI 76.7–78.6 %). Significantly higher prescribing adherence was found in the secondary care facilities, 82.4 % (95 % CI 81.2–83.6 %) compared to primary care 72.5 % (95 % CI 71.0–73.9 %) (p < 0.001). Nineteen criteria out of 43 achieved an adherence >80 % in secondary care compared to ten criteria in primary care. The documentation of patients’ records was found to be inconsistent at the study healthcare facilities. Nonoptimal achievement of target goals for HbA1c, blood pressure and BMI was prevalent among the study population. Conclusion: A tool such as MATKW highlights areas for review and possible improvement in prescribing adherence. Our findings reveal problem areas in prescribing practices and documentation of patients’ records. Cost-effective multifaceted interventions are needed to improve current prescribing practices and documentation.
Literatur
2.
Zurück zum Zitat American Diabetes Association. Standards of medical care in diabetes. Diabetes Care. 2009;32:S13–61.CrossRef American Diabetes Association. Standards of medical care in diabetes. Diabetes Care. 2009;32:S13–61.CrossRef
4.
Zurück zum Zitat Abdella N, Khogali M, Al-Ali S, Gumaa K, Bajaj J. Known Type 2 diabetes mellitus among the Kuwaiti population: a prevalence study. Acta Diabetol. 1996;33:145–9.PubMedCrossRef Abdella N, Khogali M, Al-Ali S, Gumaa K, Bajaj J. Known Type 2 diabetes mellitus among the Kuwaiti population: a prevalence study. Acta Diabetol. 1996;33:145–9.PubMedCrossRef
5.
Zurück zum Zitat Advisory Commission on Health Consumer Protection and Quality in the Health Care Industry. Quality First: Better Health Care for All Americans. Washington: U.S. Government Printing Office; 1998. Advisory Commission on Health Consumer Protection and Quality in the Health Care Industry. Quality First: Better Health Care for All Americans. Washington: U.S. Government Printing Office; 1998.
6.
Zurück zum Zitat Al-Adsani A, Al-Faraj J, Al-Sultan F, El-Feky M, Al-Mezel N, Saba W, Aljassar S. Evaluation of the impact of the Kuwait Diabetes Care Program on the quality of diabetes care. Med Princ Pract. 2008;17:14–9.PubMedCrossRef Al-Adsani A, Al-Faraj J, Al-Sultan F, El-Feky M, Al-Mezel N, Saba W, Aljassar S. Evaluation of the impact of the Kuwait Diabetes Care Program on the quality of diabetes care. Med Princ Pract. 2008;17:14–9.PubMedCrossRef
7.
Zurück zum Zitat Hakonsen GD, Hudson S, Loennechen T. Design and validation of a medication assessment tool for cancer pain management. Pharm World Sci. 2006;28:342–51.PubMedCrossRef Hakonsen GD, Hudson S, Loennechen T. Design and validation of a medication assessment tool for cancer pain management. Pharm World Sci. 2006;28:342–51.PubMedCrossRef
8.
Zurück zum Zitat Hakonsen GD, Torbergsen AL, Strelec P, Cambell D, Hudson S, Loennechen T. A medication assessment tool to evaluate adherence to medication guideline criteria in cancer pain management. Int J Pharm Pract. 2008;16:99–107.CrossRef Hakonsen GD, Torbergsen AL, Strelec P, Cambell D, Hudson S, Loennechen T. A medication assessment tool to evaluate adherence to medication guideline criteria in cancer pain management. Int J Pharm Pract. 2008;16:99–107.CrossRef
9.
Zurück zum Zitat Kamyar M, Johnson BJ, McAnaw J, Lemmens-Gruber R, Hudson S. Adherence to clinical guidelines in the prevention of coronary heart disease in type II diabetes mellitus. Pharm World Sci. 2008;30:120–7.PubMedCrossRef Kamyar M, Johnson BJ, McAnaw J, Lemmens-Gruber R, Hudson S. Adherence to clinical guidelines in the prevention of coronary heart disease in type II diabetes mellitus. Pharm World Sci. 2008;30:120–7.PubMedCrossRef
11.
Zurück zum Zitat Guidelines on diabetes, pre-diabetes and cardiovascular diseases: The Task Force on diabetes and cardiovascular diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD). Eur Heart J. 2007;9 (suppl C): C3–C74. doi: 10.1093/eurheartj/ehl261. Guidelines on diabetes, pre-diabetes and cardiovascular diseases: The Task Force on diabetes and cardiovascular diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD). Eur Heart J. 2007;9 (suppl C): C3–C74. doi: 10.​1093/​eurheartj/​ehl261.
14.
Zurück zum Zitat Diab M, Towle I, Johnson BJ, Hudson S. The quality of medication use in obesity management and in primary prevention of cardiovascular disease (CVD). Pharm World Sci. 2010;32:241. Diab M, Towle I, Johnson BJ, Hudson S. The quality of medication use in obesity management and in primary prevention of cardiovascular disease (CVD). Pharm World Sci. 2010;32:241.
15.
Zurück zum Zitat Khunti K, Ganguli S. Who looks after people with diabetes: primary or secondary care? J R Soc Med. 2000;93:183–6.PubMed Khunti K, Ganguli S. Who looks after people with diabetes: primary or secondary care? J R Soc Med. 2000;93:183–6.PubMed
16.
Zurück zum Zitat Miller R, Sim I. Physician’s use of electronic medical records: barriers and solutions. Health Aff. 2004;23:116–26.CrossRef Miller R, Sim I. Physician’s use of electronic medical records: barriers and solutions. Health Aff. 2004;23:116–26.CrossRef
17.
Zurück zum Zitat Laing RO, Hogerzeil HV, Ross-Degnan D. Ten recommendations to improve use of medicines in developing countries. Health Policy Plan. 2001;16:13–20.PubMedCrossRef Laing RO, Hogerzeil HV, Ross-Degnan D. Ten recommendations to improve use of medicines in developing countries. Health Policy Plan. 2001;16:13–20.PubMedCrossRef
18.
Zurück zum Zitat Bero LA, Grilli R, Grimshaw JM, Harvey E, Oxman AD, Thomson MA. Closing the gap between research and practice: an overview of systematic reviews of interventions to promote the implementation of research findings. The Cochrane Effective Practice and Organization of Care Review Group. BMJ. 1998;317:465–8.PubMedCrossRef Bero LA, Grilli R, Grimshaw JM, Harvey E, Oxman AD, Thomson MA. Closing the gap between research and practice: an overview of systematic reviews of interventions to promote the implementation of research findings. The Cochrane Effective Practice and Organization of Care Review Group. BMJ. 1998;317:465–8.PubMedCrossRef
19.
Zurück zum Zitat Pringle M, Stewart-Evans C, Coupland C, Williams I, Allison S, Sterland J. Influences on control in diabetes mellitus: patient, doctor, practice or delivery of care? BMJ. 1993;306:630–4.PubMedCrossRef Pringle M, Stewart-Evans C, Coupland C, Williams I, Allison S, Sterland J. Influences on control in diabetes mellitus: patient, doctor, practice or delivery of care? BMJ. 1993;306:630–4.PubMedCrossRef
20.
Zurück zum Zitat Whitley HP, Fermo JD, Ragucci K, Chumney EC. Assessment of patient knowledge of diabetic goals, self-reported medication adherence, and goal attainment. Pharm Pract. 2006;4:183–90. Whitley HP, Fermo JD, Ragucci K, Chumney EC. Assessment of patient knowledge of diabetic goals, self-reported medication adherence, and goal attainment. Pharm Pract. 2006;4:183–90.
21.
Zurück zum Zitat Clifford RM, Davis WA, Batty KT, Davis TM. Effect of a pharmaceutical care program on vascular risk factors in type 2 diabetes: the Fremantle Diabetes Study. Diabetes Care. 2005;28:771–6.PubMedCrossRef Clifford RM, Davis WA, Batty KT, Davis TM. Effect of a pharmaceutical care program on vascular risk factors in type 2 diabetes: the Fremantle Diabetes Study. Diabetes Care. 2005;28:771–6.PubMedCrossRef
22.
Zurück zum Zitat Odegard PS, Goo A, Hummel J, Williams KL, Gray SL. Caring for poorly controlled diabetes mellitus: a randomized pharmacist intervention. Ann Pharmacother. 2005;39:433–40.PubMedCrossRef Odegard PS, Goo A, Hummel J, Williams KL, Gray SL. Caring for poorly controlled diabetes mellitus: a randomized pharmacist intervention. Ann Pharmacother. 2005;39:433–40.PubMedCrossRef
23.
Zurück zum Zitat Kiel PJ, McCord AD. Pharmacist impact on clinical outcomes in a diabetes disease management program via collaborative practice. Ann Pharmacother. 2005;39:1828–32.PubMedCrossRef Kiel PJ, McCord AD. Pharmacist impact on clinical outcomes in a diabetes disease management program via collaborative practice. Ann Pharmacother. 2005;39:1828–32.PubMedCrossRef
Metadaten
Titel
Evaluation of adherence to international guidelines for treating patients with type 2 diabetes mellitus in Kuwait
verfasst von
Dalal M. Al-Taweel
Abdelmoneim I. Awad
B. Julienne Johnson
Publikationsdatum
01.04.2013
Verlag
Springer Netherlands
Erschienen in
International Journal of Clinical Pharmacy / Ausgabe 2/2013
Print ISSN: 2210-7703
Elektronische ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-012-9738-8

Weitere Artikel der Ausgabe 2/2013

International Journal of Clinical Pharmacy 2/2013 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.